A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic.
Katharina HanselA ZangrilliL BianchiKetty PerisAndrea ChiricozziA OffidaniDiotallevi FedericoMaria-Concetta FargnoliMaria EspositoP AmerioGiulio GualdiL BianchiLuca StingeniPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
Keyphrases